C41H64O14
780.9 g/mol
Aktif Farmasötik İngredientTehlike
Digoxin
Digoksin
CAS20830-75-5EC244-068-1
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Steroit
Birincil Kullanım
Farmasötik ham madde
Digoxin is a cardiac glycoside active pharmaceutical ingredient used in the manufacturing of cardiovascular medications. It is one of the oldest compounds employed in cardiology, primarily sourced as a raw material for pharmaceutical production.
Active pharmaceutical ingredient for heart failure medicationsPharmaceutical raw material for atrial fibrillation treatmentsCardiac glycoside intermediate for cardiovascular drug manufacturing
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 20830-75-5
İlgili Bileşikler
GüçlüBenzer yapıBenzerlik 0.89
Metildigoxin
CAS30685-43-9
active pharmaceutical ingredient
GüçlüBenzer yapıBenzerlik 0.85
Beta-Acetyldigoxin
CAS5355-48-6
active pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.81
Digitoxin
CAS71-63-6
cardiac glycoside pharmaceutical ingredient
BenzerBenzer yapıBenzerlik 0.80
Deslanoside
CAS17598-65-1
cardiotonic glycoside active pharmaceutical ingredient
ReferansAynı kategori
Daunorubicin
CAS20830-81-3
active pharmaceutical ingredient
ReferansAynı kategori
Micafungin sodium
CAS208538-73-2
active pharmaceutical ingredient
ReferansAynı kategori
Neptinib
CAS2085843-51-0
active pharmaceutical ingredient
ReferansAynı kategori
(+)-Vestitol
CAS20879-05-4
api standard reference material
Güvenlik Referansı
Tehlike
H300Fatal if swallowed
H330Fatal if inhaled
H319Causes serious eye irritation
H331Toxic if inhaled
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
Tanımlayıcılar
IUPAC Adı
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
InChIKey
LTMHDMANZUZIPE-PUGKRICDSA-N
SMILES
C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
Eş Anlamlılar (114)
- Digoxin (JP18/USP)
- Digoxin for peak identification, European Pharmacopoeia (EP)
- Digoxin, European Pharmacopoeia (EP)
- Digoxin, United States Pharmacopeia (USP)
- Digoxina [INN-Spanish]
- Digoxinum [INN-Latin]
- 12A-Hydroxydigitoxin
- 12b-Hydroxydigitoxin
- 12beta-Hydroxydigitoxin
- 3b0w
- Acygoxin
- Boehringer, Digoxina
- Cardigox
- Cardiogoxin
- Cardioxin
- Cardoxin
- Chloroformic digitalin
- Coragoxine
- Cordioxil
- DIGOXIN [MART.]
- Davoxin
- Digacin
- Digamex
- Digitalis glycoside
- Digitek
- Digoksyna
- Digoksyna [Polish]
- Digomal
- Digon
- Digonix
- Digos
- Digosin
- Digossina
- Digox
- Digoxigenin-tridigitoxosid
- Digoxin 1.0 mg/ml in Methanol
- Digoxin CRS
- Digoxin Nativelle
- Digoxin Pediatric
- Digoxin RS
- Digoxin, 1mg/ml in Methanol
- Digoxin-Sandoz
- Digoxin-Zori
- Digoxina
- Digoxina-Sandoz
- Digoxine
- Digoxine Navtivelle
- Digoxinum
- Dilanacin
- Dimecip
- Dixina
- Dokim
- Dynamos
- Eudigox
- Fargoxin
- Grexin
- Hemigoxine Nativelle
- Homolle's digitalin
- LANOXIN PEDIATRIC
- Lanacordin
- Lanacrist
- Lanikor
- Lanocardin
- Lanorale
- Lanoxicaps
- Lanoxicaps (TN)
- Lanoxin
- Lanoxin (TN)
- Lanoxin PG
- Lenoxicaps
- Lenoxin
- Lifusin
- Mapluxin
- Natigoxin
- Nativelle, Digoxine
- Nativelle, Hemigoxine
- Neo-Lanicor
- Neodioxanin
- Novodigal [inj.]
- Purgoxin
- Rougoxin
- SK-Digoxin
- Saroxin
- Stillacor-
- Toloxin
- Vanoxin
- [3H]digoxin
- digoxin